10-Q: Huntsman Corporation and Huntsman International LLC Report Mixed Results in Q2 2024
Quarterly Report
Huntsman Corporation and Huntsman International LLC reported a decrease in revenue and profitability for the second quarter of 2024, impacted by lower average selling prices, despite increased sales volumes.
Summary
- Huntsman Corporation and Huntsman International LLC reported a decrease in revenue for the second quarter of 2024, with revenues at $1.574 billion, down from $1.596 billion in the same period last year.
- Gross profit also decreased to $243 million from $254 million year-over-year.
- The company experienced a net loss of $15 million for the first six months of 2024, compared to a net income of $172 million for the same period in 2023.
- Adjusted EBITDA for the second quarter was $131 million, down from $156 million in the prior year.
- The company's performance was impacted by lower average selling prices across all segments, although sales volumes increased in Polyurethanes and Performance Products.
- The company completed the separation and acquisition of assets of Shanghai Lianheng Isocyanate Company Ltd. (SLIC) on January 31, 2024, resulting in a bargain purchase gain of approximately $51 million and a write-off of certain prepaid assets of approximately $71 million.
- The company's liquidity position includes $335 million in cash, $949 million in availability under the 2022 Revolving Credit Facility, and $50 million in availability under A/R Programs as of June 30, 2024.
Sentiment
Score: 4
Explanation: The document presents a mixed picture with some positive aspects like increased sales volumes and a gain from an acquisition, but the overall sentiment is negative due to decreased revenue, profitability, and a net loss for the first six months of the year. The company is facing significant headwinds and needs to improve its performance.
Positives
- Sales volumes increased in all segments, partially offsetting the impact of lower average selling prices.
- The company recognized a $51 million gain from the acquisition of SLIC assets.
- The company successfully extended the maturity dates of its U.S. and EU A/R Programs to 2027.
- The company's liquidity position remains strong with significant cash and available credit.
Negatives
- Revenue decreased by 1% in Q2 2024 compared to Q2 2023.
- Gross profit decreased by 4% in Q2 2024.
- Adjusted EBITDA decreased by 16% in Q2 2024.
- The company experienced a net loss of $15 million for the first six months of 2024.
- The company wrote off $71 million in prepaid assets related to the SLIC acquisition.
- The company's performance was impacted by lower average selling prices across all segments.
Risks
- The company is exposed to market risks, such as changes in interest rates, foreign exchange rates, and commodity prices.
- The company's performance is subject to fluctuations in supply and demand dynamics, particularly in the MDI market.
- The company faces competitive pressure, particularly in Europe and the Americas, which impacts average selling prices.
- The company's restructuring programs may result in additional expenses and may not achieve the anticipated cost savings.
- The company's legal proceedings, including the Praxair/Linde case, are subject to further potential review and the timing of resolution is uncertain.
Future Outlook
The company expects to spend between $180 million to $200 million on capital expenditures in 2024 and anticipates making additional contributions to pension and other postretirement benefit plans of approximately $15 million during the remainder of 2024. The company also expects to complete the liquidation of the SLIC joint venture in 2025.
Industry Context
The report indicates that Huntsman is facing challenges common in the chemical industry, including fluctuating raw material costs, competitive pricing pressures, and varying demand across different markets. The company's focus on restructuring and cost optimization reflects a broader trend in the industry to improve efficiency and profitability in a challenging economic environment.
Comparison to Industry Standards
- Huntsman's performance is being impacted by similar factors affecting other chemical companies, such as lower average selling prices and fluctuating raw material costs.
- Compared to companies like Dow and BASF, Huntsman's revenue decline is in line with the industry trend of reduced demand and pricing pressures.
- Huntsman's focus on restructuring and cost optimization is a common strategy among chemical companies to improve profitability in a challenging market.
- The company's adjusted EBITDA margin of approximately 8.3% is lower than some of its peers, indicating a need for further cost optimization and efficiency improvements.
- The company's debt levels are comparable to other companies in the sector, but the company's focus on extending the maturity of its A/R programs is a positive step towards managing its financial obligations.
Legal Proceedings
- On April 19, 2024, the Louisiana Fourth Circuit Court of Appeal affirmed the $93.1 million jury verdict and district court judgment in our favor in our long-running court battle against Praxair/Linde.
Related Party Transactions
- Huntsman International declared and paid to us distributions in the form of certain affiliate accounts receivable during 2024 and 2023.
Stakeholder Impact
- Shareholders may be concerned about the decrease in profitability and the net loss for the first six months of 2024.
- Employees may be affected by the ongoing restructuring programs and potential workforce reductions.
- Customers may experience changes in pricing and product availability due to market fluctuations and the company's restructuring efforts.
- Creditors may be monitoring the company's debt levels and liquidity position.
Next Steps
- The company expects to spend between $180 million to $200 million on capital expenditures in 2024.
- The company anticipates making additional contributions to pension and other postretirement benefit plans of approximately $15 million during the remainder of 2024.
- The company expects to complete the liquidation of the SLIC joint venture in 2025.
Key Dates
| Date | Description |
|---|---|
| 2021-10-26 | Board of Directors approved a share repurchase program of $1 billion. |
| 2022-03-25 | Board of Directors increased the authorization of the share repurchase program to $2 billion. |
| 2022-05-20 | Huntsman International entered into a $1.2 billion senior unsecured revolving credit facility. |
| 2023-02-28 | Completed the sale of the Textile Effects Business to Archroma. |
| 2024-01-22 | Entered into an amendment to the U.S. A/R Program, extending the maturity date to January 2027. |
| 2024-01-31 | Completed the separation and acquisition of assets of Shanghai Lianheng Isocyanate Company Ltd. (SLIC). |
| 2024-01-31 | Entered into an amendment to the EU A/R Program, extending the maturity date to July 2027, effective February 15, 2024. |
| 2024-04-19 | Louisiana Fourth Circuit Court of Appeal affirmed the $93.1 million jury verdict in the Praxair/Linde case. |
| 2024-06-30 | End of the reporting period for the quarterly report. |
| 2024-08-06 | Date of the report. |
Keywords
Huntsman, Polyurethanes, Performance Products, Advanced Materials, MDI, EBITDA, Restructuring, Acquisition, Debt, Liquidity, Chemicals, Financial Results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.